If standard fertility treatments haven’t worked for you — particularly with very low ovarian reserve or premature ovarian insufficiency — you may have come across autologous stem cell therapy in your search for options.
Before anything else, here’s the most important thing to know: this is an investigational treatment in India, not an established, routine therapy. Any clinic offering it should say this clearly, upfront, before you consider it.
This article explains what autologous stem cell therapy actually is, what the current evidence says, and what to expect if you’re exploring it under a research protocol.
What Is Autologous Stem Cell Therapy for Infertility?
“Autologous” means the stem cells come from your own body — not a donor. In the context of fertility, this typically involves collecting stem cells (often from bone marrow) and introducing them into the ovaries, with the theoretical goal of supporting ovarian tissue function in women with very diminished ovarian reserve.
The idea is still being actively researched. It is not a guaranteed way to restore fertility, and it doesn’t work the same way for everyone it’s tried on.
Important: This Is Classified as Investigational in India
The Indian Council of Medical Research (ICMR) explicitly classifies stem cell use for infertility as investigational. This means:
- It should only be offered as part of a registered clinical research protocol, not as a routine, guaranteed clinical service
- Patients must give informed consent that clearly acknowledges the experimental nature of the treatment
- Any clinic promising “guaranteed pregnancy” or similarly certain outcomes from this treatment should be treated as a serious red flag
A recent Supreme Court judgment (January 2026) further reinforced that stem cell interventions lacking sufficient scientific evidence cannot be offered as routine clinical services in India. This isn’t a technicality — it reflects the genuine, current state of scientific evidence.
Who Might Be Considered for This Approach?
Given its investigational status, this approach is typically discussed only for a narrow group of patients — generally those with:
- Premature ovarian insufficiency (POI) or very significantly diminished ovarian reserve
- Repeated failed IVF cycles due to poor ovarian response, where conventional options have been exhausted
- A clear understanding that this is a research-based approach, not a standard treatment path
It’s generally not considered appropriate for women with completely atrophied ovaries or those well past menopause, given very limited likelihood of any meaningful response in these cases.
What Does the Process Generally Involve?
While specific protocols vary between research programmes, the general process typically includes:
- Thorough diagnostic evaluation to confirm eligibility and rule out other treatable causes
- Detailed counselling and informed consent, explaining the experimental nature, potential risks, and realistic expectations
- Stem cell collection, typically from bone marrow
- Processing and introduction of the prepared cells into the ovaries
- Monitoring, to assess any changes in ovarian markers and response over subsequent cycles
Every step should be documented as part of a research protocol, with the patient’s full understanding that outcomes are not predictable or guaranteed.
What Does the Current Evidence Say?
Research in this area is still early-stage. Some studies have reported changes in hormonal markers or occasional pregnancies in small patient groups, but the overall body of evidence remains limited, with small sample sizes and inconsistent results across studies globally.
This means:
- It cannot be presented as a proven fertility solution
- It should not be positioned as a replacement for established treatments like IVF, donor egg options, or other conventional approaches, when those remain viable
- Anyone considering it should treat it as a research participation decision, not a standard treatment choice
Questions to Ask Before Considering This Treatment
- Is this being offered under a registered research protocol?
- What does the informed consent document say about expected outcomes?
- What are the known risks of the collection and introduction procedure?
- What happens if there’s no response — what are the next steps?
- Has the clinic been transparent about the limited, evolving evidence base?
A reputable specialist will welcome these questions and answer them directly, without pressure to proceed.
Cost Considerations
Because this is a research-based, investigational approach rather than a standardised treatment, cost structures can vary significantly between institutions and depend on the specific protocol, monitoring required, and any associated diagnostic work-up.
We’d strongly encourage discussing cost transparently as part of the informed consent conversation, alongside the discussion of expected outcomes and risks.
Our Approach at Sree Swapna Fertility Centre
At Sree Swapna Fertility Centre, we take the investigational nature of autologous stem cell therapy seriously. Our clinical director, Dr. Swapna Naik (MBBS, MS in Obstetrics & Gynaecology, Fellowship in Reproductive Medicine & IVF), brings over 15 years of experience in reproductive medicine and has guided more than 5,000 successful pregnancies through established fertility treatments.
For patients who have exhausted conventional options and are exploring this research-based approach, we ensure full, honest counselling before any decision is made — including a clear explanation of the current evidence, realistic expectations, and the informed consent process required under applicable research guidelines.
We will never present this treatment as a guaranteed path to pregnancy. If conventional treatment — including IVF, donor egg options, or other approaches — remains a realistic and better-evidenced path for you, we’ll say so first.
Frequently Asked Questions
1. Is autologous stem cell therapy for infertility approved in India?
No, it’s classified as investigational by ICMR, meaning it can only be offered under registered research protocols, not as a routine approved treatment.
2. Does stem cell therapy guarantee pregnancy?
No. There’s no guarantee of pregnancy, and any clinic claiming otherwise should be treated with caution.
3. What does “autologous” mean in this context?
It means the stem cells come from the patient’s own body, typically from bone marrow, rather than from a donor.
4. Who might this treatment be considered for?
Generally women with premature ovarian insufficiency or very diminished ovarian reserve who have exhausted conventional fertility treatment options.
5. Is this the same as IVF?
No, it’s a separate, investigational approach sometimes explored alongside or before IVF in specific cases, not a replacement for it.
6. What are the risks of the procedure?
Risks are generally associated with the bone marrow collection procedure and cell introduction, similar to other minimally invasive procedures. Discuss specific risks with your specialist.
7. How is this different from egg freezing or donor eggs?
Egg freezing and donor egg treatments are established, well-evidenced options. Stem cell therapy remains investigational with a much smaller evidence base.
8. Can this help women who are already in menopause?
Its likelihood of meaningful response is considered very low in women with completely atrophied ovaries or well past menopause.
9. Is informed consent required for this treatment?
Yes, and it should explicitly acknowledge the experimental nature of the treatment, as required by research ethics guidelines.
10. How long does the process take?
This varies by protocol and individual response, and should be discussed in detail during your consultation.
11. Is this treatment available at every fertility clinic in India?
No, it’s only appropriately offered by clinics operating within a registered research framework, with proper ethical oversight.
12. What happens if the treatment doesn’t produce a response?
Your specialist should discuss alternative options, including established treatments, as part of your overall care plan.
13. Are there published success rate statistics for this treatment?
Evidence remains limited and inconsistent globally, so reliable, generalisable success rate statistics aren’t currently well established.
14. Should I get a second opinion before considering this treatment?
Yes, given its investigational status, a second opinion is a reasonable and encouraged step.
15. Does Sree Swapna Fertility Centre offer this treatment to everyone?
No, it’s considered only for a narrow group of patients who meet specific criteria and have exhausted conventional treatment options, following thorough counselling.
16. Is this treatment reversible or does it carry long-term risks?
Long-term data is still limited. This should be discussed thoroughly as part of the informed consent process before proceeding.
17. Can I ask to see the research protocol before agreeing to treatment?
Yes, and a transparent clinic should be willing to explain the framework under which the treatment is being offered.
18. Is this treatment recommended as a first option for infertility?
No, it’s generally considered only after conventional, well-evidenced treatments haven’t been successful.
19. How is eligibility for this treatment determined?
Through a thorough diagnostic evaluation, including hormonal testing and ovarian reserve assessment, along with a review of prior treatment history.
20. What should I look out for if a clinic seems to oversell this treatment?
Be cautious of clinics that promise guaranteed results, downplay the experimental nature, or don’t provide clear informed consent documentation.
Conclusion
Autologous stem cell therapy for infertility represents a genuinely researched area of reproductive medicine, but it remains investigational in India — not an established, guaranteed solution. If you’re exploring this option, the most important step is finding a clinic that’s transparent about the evidence, the risks, and the honest likelihood of success, rather than one that overstates what’s currently known.
Discuss Your Options With Our Team
If conventional fertility treatments haven’t worked for you, Dr. Swapna Naik and the team at Sree Swapna Fertility Centre can walk you through all available options — including honest counselling on investigational approaches — so you can make a fully informed decision.
📞 Call: +91 76708 04424 / +91 40 4995 3719 💬 WhatsApp: Message us directly 📧 Email: sreeswapna.fertility@gmail.com 📍 Visit us at: Kondapur (flagship centre) or Attapur, Hyderabad 🌐 Book an appointment: sreeswapnaivf.com/contact-us
